Form D · Pharmaceuticals

Tolera Therapeutics Inc

Kalamazoo, MI · CIK 0001451072

Offering snapshot reported Sep 17, 2014 · SEC filing

Reported sold
$250K
Indefinite offering
Investors reported
2
Form D · investor count
Minimum accepted
$1K
Reported outside-investor minimum
First sale
Sep 11, 2014
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 17, 2014Initial$250,000No comparison2SEC filing
Oct 8, 2013Initial$1,052,710No comparison11SEC filing
Oct 5, 2012Initial$5,406,298No comparison24SEC filing
Aug 22, 2012Initial$750,050No comparison18SEC filing
May 15, 2012Initial$1,465,000No comparison10SEC filing
Dec 21, 2011Initial$883,333No comparison11SEC filing
Jun 3, 2010Initial$4,056,000No comparison5SEC filing
Nov 20, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Debt, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-224862

Source: Form D, filed Sep 17, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Suzette Dutch Director
James Herrmann Executive
Douglas Morton Director
Mark Olesnavage Director
Ashleigh Palmer Executive
Donald Parfet Director
John Puisis Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
350 East Michigan Avenue Suite 205
Kalamazoo, MI, 49007